Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds for uses in pharmacological induction of HBF for treatment of sickle cell disease and ß-thalassemia

Compounds for uses in pharmacological induction of HBF for treatment of sickle cell disease and ß-thalassemia

US Patent 12246021 · Granted Mar 11, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

TDP-43 knock-in mouse model of amyotrophic lateral sclerosis2023
Thiazole compounds as protein kinase inhibitors2022
Methods for enhancing lifespan and/or treating cellular proliferative disorders 2022
Animal model of longevity and related methods for increasing longevity and inhib2022
Animal model of longevity and related methods for increasing longevity and inhib2019
Aminothiazole compounds as protein kinase inhibitors2019
Aminothiazole compounds2018
Methods for rescuing learning and/or memory deficits caused by alzheimer's disea2017
DNA 5-methyl cytosine demethylation activity of vertebrate DNA methyltransferase2017
Methods and compositions for treating β-thalassemia and sickle cell disease2017
Pyrazole compounds and thiazole compounds as protein kinases inhibitors2016
Methods for treating frontotemporal lobar degeneration with ubiquitinated inclus2015